A detailed history of Cerity Partners LLC transactions in Genmab A/S stock. As of the latest transaction made, Cerity Partners LLC holds 48,003 shares of GMAB stock, worth $961,500. This represents 0.0% of its overall portfolio holdings.

Number of Shares
48,003
Previous 41,900 14.57%
Holding current value
$961,500
Previous $1.05 Million 11.22%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$23.84 - $28.48 $145,495 - $173,813
6,103 Added 14.57%
48,003 $1.17 Million
Q2 2024

Aug 13, 2024

SELL
$25.13 - $30.27 $182,041 - $219,275
-7,244 Reduced 14.74%
41,900 $1.05 Million
Q1 2024

May 14, 2024

SELL
$26.43 - $32.77 $156,174 - $193,637
-5,909 Reduced 10.73%
49,144 $1.47 Million
Q4 2023

Jan 26, 2024

BUY
$27.94 - $35.44 $1.19 Million - $1.51 Million
42,661 Added 344.26%
55,053 $1.75 Million
Q3 2023

Nov 13, 2023

SELL
$35.27 - $42.24 $1.84 Million - $2.2 Million
-52,072 Reduced 80.78%
12,392 $437,000
Q2 2023

Aug 14, 2023

BUY
$37.4 - $42.94 $1,047 - $1,202
28 Added 0.04%
64,464 $2.45 Million
Q1 2023

May 11, 2023

SELL
$34.88 - $43.22 $96,896 - $120,065
-2,778 Reduced 4.13%
64,436 $2.43 Million
Q4 2022

Feb 15, 2023

BUY
$33.8 - $47.06 $36,233 - $50,448
1,072 Added 1.62%
67,214 $2.85 Million
Q3 2022

Nov 10, 2022

BUY
$31.52 - $373.61 $163,336 - $1.94 Million
5,182 Added 8.5%
66,142 $2.13 Million
Q2 2022

Aug 10, 2022

BUY
$26.83 - $38.57 $140,320 - $201,721
5,230 Added 9.38%
60,960 $1.98 Million
Q1 2022

Apr 25, 2022

SELL
$30.95 - $39.68 $350,323 - $449,137
-11,319 Reduced 16.88%
55,730 $2.02 Million
Q4 2021

Feb 14, 2022

BUY
$35.87 - $47.12 $270,639 - $355,520
7,545 Added 12.68%
67,049 $2.65 Million
Q3 2021

Oct 25, 2021

SELL
$41.55 - $48.72 $6,938 - $8,136
-167 Reduced 0.28%
59,504 $2.6 Million
Q2 2021

Aug 11, 2021

BUY
$32.88 - $44.57 $2,170 - $2,941
66 Added 0.11%
59,671 $2.44 Million
Q1 2021

Aug 11, 2021

BUY
$30.92 - $44.4 $247 - $355
8 Added 0.01%
59,605 $1.96 Million
Q1 2021

May 12, 2021

SELL
$30.92 - $44.4 $83,453 - $119,835
-2,699 Reduced 4.33%
59,597 $1.96 Million
Q4 2020

Feb 11, 2021

BUY
$33.66 - $40.76 $250,396 - $303,213
7,439 Added 13.56%
62,296 $2.53 Million
Q3 2020

Nov 12, 2020

BUY
$33.07 - $38.68 $1.81 Million - $2.12 Million
54,857 New
54,857 $2.01 Million
Q4 2019

Feb 14, 2020

SELL
$18.88 - $24.14 $232,979 - $297,887
-12,340 Closed
0 $0
Q3 2019

Oct 30, 2019

BUY
$18.0 - $21.38 $222,120 - $263,829
12,340 New
12,340 $250,000

Others Institutions Holding GMAB

About GENMAB A/S


  • Ticker GMAB
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 658,292,992
  • Market Cap $13.2B
  • Description
  • Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...
More about GMAB
Track This Portfolio

Track Cerity Partners LLC Portfolio

Follow Cerity Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cerity Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cerity Partners LLC with notifications on news.